Health Care
More on Health Care
Cummings Issues Statement on New CBO Report on TrumpCare
Washington, D.C. (May 24, 2017)—Today, Congressman Elijah E. Cummings (D-MD), Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement after the Congressional Budget Office (CBO) issued its new report on TrumpCare:
Washington D.C. – Today, Senior Democrats introduced H.R. 1776, the Improving Access to Affordable Prescription Drugs Act. This comprehensive legislation would lower drug prices for patients and taxpayers while spurring innovation. The bill proposes a broad range of solutions, which are explained in further detail here.
Sanders, Cummings Investigate Unusual Circumstances Surrounding FDA Approval of Muscular Dystrophy Drug
WASHINGTON, March 15 – Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.), ranking member of the House Committee on Oversight and Government Reform, sent a letter to the Food and Drug Administration Wednesday requesting information about the unusual circumstances surrounding the approval of Emflaza – a brand name version of a drug used to treat a deadly genetic muscle deterioration disorder.
Cummings Condemns GOP Health Repeal Bill After CBO Report Finds 14 Million Would Lose Health Coverage Next Year
Washington, D.C. (March 13, 2017)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, issued the following statement after the nonpartisan Congressional Budget Office (CBO) released a report concluding that 14 million Americans would lose health insurance coverage in 2018 if Republicans pass their bill to repeal the Affordable Care Act:
Democratic Report Examines the Impact of ACA Repeal, Particularly in Republican Congressional Districts
Affordable and Safe Prescription Drug Importation Act Introduced to Help Lower Skyrocketing Cost of Medicine
WASHINGTON, Feb. 28 – Sens. Bernie Sanders (I-Vt.), Cory Booker (D-N.J.) and Bob Casey (D-Penn.) introduced legislation Tuesday to lower the skyrocketing cost of prescription drugs by allowing Americans to import safe, low-cost medicine from Canada. Reps. Elijah E. Cummings (D-Md.) and Lloyd Doggett (D-Texas) introduced a companion bill in the House.
Cummings Opposes Legislation to Prioritize Corporate Profits Over Public Health and Safety
Washington, D.C. (Feb. 28, 2017)—Today, Rep. Elijah E. Cummings, Ranking Member of the House Committee on Oversight and Government Reform, spoke on the House floor, in opposition to H.R. 998, the Searching for and Cutting Regulations that are Unnecessarily Burdensome Act of 2017, or SCRUB Act.